Influence of strenuous exercise on albumin excretion by Krämer, Bernhard K. et al.
2516 CLINICALCHEMISTRY, Vol.34, No. 12, 1988
Role of CA 125 as a tumor marker in ovarian carcinoma, Obstet
Gynecol 1986;67:473-7.
11. Brioschi PA, BischofP. Rapin C, De Roten M, Irion 0, Krauer
F. Longitudinal study of CEA and CA 125 in ovarian cancer.
Gynecol Oncol 1985;21:1-6.
12. Altaras MM, Goldberg GL, Levin W, Darge L, Bloch B, Smith
JA. The value of cancer antigen 125 as a tumor marker in
malignant germ cell tumors of the ovary. Gynecol Oncol
1986;25:150-9.
13. Petersifi WA, BagleyCM, Smith MR. CA-125 use as a tumor
marker with mixed mesodermal tumors of the femalegenital tract.
Cancer 1986;58:2625-7.
14. Atack DB, Nisker JA, Allen H}I, Tustanofi’ EF, L.evin L. CA
125surveillance andsecond-looklaparotomy in ovarian carcinoma.
Am J Obstet Gynecol 1986;154:287-9.
15. Niloff JM, Bast Jr Re, Schaetzl EM, Knapp RC. Predictive
value of CA 125 antigen levels in second-look procedures for
ovarian cancer. Am J Obstet Gynecol 1985;151:981-6.
16. Shelley MD, Fish RG. Evaluation of an inununoradiometric
assay for the detection of an ovarian tumour marker, CA 125, in
serum. Ann Clin Biochem 1986;23:292-6.
17. Packageinsert, Abbott CA 125-EIA Monoclonal. North Chica-
CLIN. CHEM. 34/12, 2516-2518 (1988)
go, IL 60064: Abbott Laboratories, Diagnostics Division, 1987.
18. Galen RS, Gambino SR. Beyond normality. New York: John
Wiley and Sons,1975:13,33.
19. Westgard JO, Hunt MR. Use and interpretation of common
statistical tests in method-comparison studies. Clin Chem
1973;19:49-57.
20. Beck JR. Shultz EK. The use of relative operating characteris.
tic (ROC) curves in test performance evaluation. Arch Pathol Lab
Med 1986;11O:13-20.
21. Glick MR, Ryder KW, Jackson SA. Graphical comparisons of
interferences in clinical chemistry instrumentation. Clin Chem
1986;32:470-.5.
22. Dhokia B, Canney PA, Pectasides D, et al. A new immunoassay
using monoclonal antibodies HMGF1 and HMFG2 together with an
existing marker CA125 for the serological detection and manage-
ment of epithelial overian cancer. Br J Cancer 1986;54:891-5.
23. Patton PE, Field CS, Harms RW, Coulam CB. CA-125 levels in
endometriosis. Fertil Steril 1986;45:770-3.
24. Mastropaolo W, Fernandez Z, Miller EL. Pronouncedincreases
in the concentration of an ovarian tumor marker CA-125, in serum
ofa healthy subjectduring menstruation. Clin Chem 1986;32:2110-
1.
Influence of StrenuousExerciseon AlbuminExcretion
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Renal albumin excretion rate was 7.3 mg/24 h (SEM 0.5,
range 0.6-21.0) in 66 healthy subjects. This rate increased
markedly during and shortly after strenuous exercise on a
bicycle ergometer (before: 5.5 ± 0.6 &gJmin; during and just
after: 16.9 ± 2.2 tg/min; P <0.001; n = 30). However,
albumin excretion/24 h was not significantly higher during 24
h with a period of strenuous exercise than during 24 h without
such exercise (10.3 ± 0.9 mg/24 h vs 8.5 ± 0.7 mg/24 h).
Additional Keyphrasee: albuminuna . diabetes . diabetic
nephropathy
End-stage renal disease develops in about 40% of insulin-
dependent diabetics (1, 2), overt proteinuria (>500 mg of
protein or >300 mg of albumin excreted in 24 h) being the
hallmark of diabetic nephropathy and a serious prognostic
marker (1-3). PauciC’micro”)albuminuria is a strong predic-
tor of future overt nephropathy (4,5) in diabetic patients.
Early paucialbuminuria can be stopped or even reversed by
means of better control of blood glucose or of blood pressure
(3,6, 7), thus probably slowing or even preventing develop-
ment of overt diabetic nephropathy. Exact estimation of a
slight albuminuria is also of interest for the control of
patients with hypertension (8). Our aim in this study was to
examine whether 24-h albumin excretion is altered mislead-
ingly by a rather brief period of strenuous exercise during
the urine-collection period.
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MaterIals and Methods
Urinary albumin was measured by enzyme-linked im-
munosorbent assay as described previously (9). Urine sam-
ples were collected in 2-L casein-coated polyethylene con-
tainers (9). Albumin excretion was measured in 24-h collec-
tions of urine from 66 apparently healthy subjects (eight
men and 10 women, ages 20-29 y; 10 men and 10 women,
ages 30-39 y; eight men and 10 women, ages 40-49 y; and
five men and five women, ages 50-55 y). In 30 of those
subjects (five of each sex in the age ranges 20-29, 30-39,
and 40-50 y) the 24-h collections were made as two 12-h
collections (one from 0700 to 1900 hours, the second over-
night from 1900 to 0700 hours) to contrast night-time with
daytime excretion. With the same 30 subjects, we estimated
albumin excretion rate before (period I), during and shortly
after (period H), and after (period RI) strenuous exercise.
Period I lasted from 0700 to the start of the exercise, period
U from the start of the exercise until 1 h after the end of the
exercise, and period RI from 1 h after the exercise until 0700
hours on the next day.
Results from periods I, II, and RI were pooled to provide a
24-h period including exercise, which could then be com-
pared with a 24-h period without exercise in the same
subject. The two 24-h urine collections were done within one
week, but not on consecutive days. The subjects performed
strenuous exercise on a bicycle ergometer (Keiper Dynavit;
Meditronic 40/2, 6750 Kaiserslautern, F.R.G.), according to
the following protocol: Start with a workload of 30 W (J/s, or
kgm2s3) for3minandincrease to70Wfor3min,then
further increase the workload by 40 W every 3 mm until
physical exhaustion. Blood pressure was measured with a
sphygmomanometer. A statistical evaluation was by means
of paired t-test; data are reported as mean ± SEM.
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Results
For the 66 healthy subjects, the mean 24-h albumin
excretion was 7.3 ± 0.5 mg/24 h (range 0.6-21.0), being 7.8
± 0.8 (2.0-21.0) mg/24 h for the women and 6.7 ± 0.7 (0.6-
19.5) mg/24 h for the men. The 12-h albumin excretion was
significantly higher (P <0.05) during day (4.9 ± 0.6 mg/12
h) than night (3.6 ± 0.3 mg/24 h) in 30 of those healthy
controls. Albumin excretions per 24 h by those 30 normal
controls during the day of maximal exercise (10.3 ± 0.9
mg/24 h) and during a day without exercise (8.5 ± 0.7 mg/24
h) were not significantly different. Albumin excretion rates
were significantly higher during period II (16.9 ± 2.2
pg/mm; P <0.001), during period 111(7.2 ± 0.8 pg/min, P
<0.05), and during period H and III (7.9 ± 0.8 pg/min, P
<0.01) than during period I (5.5 ± 0.6 pg/mm). Blood
pressure rose from 119.0 (±1.6)/77.7 (± 1.2) mmHg to 171.2
(±2.7)/92.8 (± 1.5) mmHg at the end of maximal exercise,
and the heart rate increased from 76.4 (± 1.4) beats/mm to
164.4 (±2.5) beats/mn. Maximum workload was 194.7 ±
9.5 W. Albumin excretion per 24 h exceeded the range of
normal values in one patient during the day of maximal
exercise (25.0 mg/24 h) compared with a day without
exercise (12.1 mg/24 h); all other values remained within
the normal range.
DIscussIon
An increase in albumin excretion during exercise has
been demonstrated both in healthy controls [maximal (10-
13) or submaximal (14) exercise] and in patients [diabetics,
hypertensives; maximal (12, 13) or submaximal (13-19)
exercise] by various authors, whereas several authors have
found no increase in albumin excretion during exercise in
healthy controls (submaximal exercise: 12, 13, 15-19) or in
diabetics [maximal (11) or submaximal (12) exercise]. To
summarize: increased albumin excretion was demonstrated
either in healthy controls or patients during maximal
exercise; and during submaximal exercise most authors
showed an increase of urinary albumin excretion in diabet-
ics but not in healthy controls. No information is available
regarding the influence of a short period of maximal or
submaximal exercise on 24-h urinary albumin excretion
(10-19).
In agreement with those results, we found that the
albumin excretion rate increased markedly during and
shortly after maximal exercise in the present study, where-
as it was only slightly increased during a later urine-
collection period (1 h after the end of exercise until the next
morning), and 24-h albumin excretion was not significantly
increased during the day that included maximal exercise.
However, a possible minor increase in urinary albumin
excretion during the day with exercise could have been
masked by the known high day-to-day variation (20-25).
Indeed, one patient had slightly increased albumin excre-
tion during the day of maximal exercise. We also saw a
higher albumin excretion in daytime than overnight, in
accordance with the results of other investigators (24-2 7).
We conclude that urines collected to check for albumin-
uria need not be discarded because of a short period of
exercise during the collection period, although it is prefera-
ble to avoid exercise within that period. However, high day-
to-day variation may necessitate several estimations, espe-
cially if high excretion rates have been detected. Random
short-time urine collections may give misleading results
because of a prior period of exercise (28). In addition, the
effect of exercise may be more marked in patients who are
already slightly albuminuric. When overnight urine is used
for screening, investigators must keep in mind that albumin
excretion is lower during night-time.
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Total urinary nitrogen (TUN) determinations for nitrogen-
balance studies were traditionally performed by the Kjeldahl
method, but this method is laborious, hazardous, prone to
error, and no longer widely available in most clinical labora-
tories. During the last several decades, urinary urea nitrogen
(UUN) determinations have replaced TUN as an index of
urinary nitrogen excretion in many clinical laboratories, owing
to its ease of determination, decreased cost, and wide
availability. However, the validity of using UUN for estimating
nitrogen loss has been questioned in many disease states,
owing to wide variations in the proportional amount of urea
found in TUN. Chemiluminescence has been proposed as an
alternative to the Kjeldahl method for TUN. TUN values
obtained from 24-h urine collections measured by both
micro-Kjeldahl (x) and Pyrochemiluminescence’” ( (Antek
Instruments, Inc.) techniques were comparable by linear
regression analysis: n = 97; r = 0.996; r2 = 0.992; y =
1.048x - 0.606; P <0.001. Automated induction of samples
and calculation of results allows up to 42 samples to be run
unattended. This dramatically reduces labor and overall
costs for TUN determinations, while providing a more accu-
rate and economical assessment of nitrogen excretion than
UUN in a clinical setting.
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The Kjeldahl procedure is the one most widely used for
measuring nitrogen in analytical chemistry (1). Determina-
tion of total urinary nitrogen (TUN) reflects the extent to
which protein catabolism (proteolysis) is occurring after
polytrauma or surgical insult or, in some disorders, the
extent to which protein malnutrition is occurring.5 In many
clinical settings, nitrogen balance determinations based on
‘FUN data are an important component of nutrition assess-
ments. TUN determinations by the Kjeldahl method have
been criticized as being costly, hazardous, and time consum-
ing. Today, the current micro-Kjeldahl method is safer than
the older technology and, although it is slow and expensive,
it is still used in many clinical laboratories for ‘FUN
determinations.
Urinary urea nitrogen (UUN), because of its lower cost,
assay rapidity, and availability, has been proposed as an
alternative index of nitrogen excretion for calculating nitro-
gen balance (2-4). However, the validity of using UUN for
estimating nitrogen loss in many disease states (i.e., renal
failure and liver disease) has been questioned (5).
A practical instrumental method for measuring the nitro-
gen content of substances by chemiluminescence was first
used in the petrochemical industry to determine the nitro-
gen content of petroleum products (6). Shortly thereafter,
Ward et al. (7), using a modified chemiluminescence analyz-
er, were able to adapt the concepts of chemiluminescence to
measure nitrogen in biological fluids. Other studies (8, 9),
involving 24-h human urine specimens, have shown an
excellent correlation between classic Kjeldahl analysis and
chemiluminescence.
Here we compare the time- and cost-effectiveness of ‘FUN
analysis by chemiluminescence with a Model 703C Pyre-
chemiluininescent’” nitrogen system (Antek Instruments,
inc., Houston, TX 77076) with that by traditional Kjeldahl
techniques. We also expand our findings for comparison
studies between the Pyrochemiluminescence and micro-
Kjeldahl technique previously reported (9).
5Nonstandard abbreviations: TUN, total urinary nitrogen; UUN,
urinary urea nitrogen;and PCL, Pyrochemiluminescent.
